Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tecfidera effects on brain white matter integrity, functional adaptation, and cognition in relapsing-remitting multiple sclerosis
NL-OMON21490Recruiting
- Sponsor
- Biogen
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of dimethyl fumarate in multiple sclerosis (MS) (3 arms), sponsored by Biogen. Primary endpoint: Change in diffusion tensor imaging white matter integrity measures. Started Apr 2018; status: recruiting.
02
Drugs
dimethyl fumarate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NL-OMON21490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21490.